Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Integrated Biopharma Inc INBP

Consumer Defensive Household & Personal Products
Integrated Biopharma Inc. is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements, and herbal products. The Company’s business segments include Contract Manufacturing operated by Manhattan Drug Company, Inc. (MDC), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health... see more

Recent & Breaking News (OTCQX:INBP)

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024

Accesswire 8 days ago

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2023

Accesswire February 12, 2024

Integrated BioPharma Reports Results for its Quarter Ended September 30, 2023

Accesswire November 9, 2023

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2023

Accesswire September 15, 2023

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2023

Accesswire May 11, 2023

Integrated BioPharma Announces the Sudden Death of Its Executive Chairman and President

Accesswire March 21, 2023

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2022

Accesswire February 10, 2023

Integrated BioPharma Reports Results for Its Quarter Ended September 30, 2022

Accesswire November 10, 2022

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2022

Accesswire September 13, 2022

Integrated BioPharma Announces Change in Directors

Accesswire June 21, 2022

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2022

Accesswire May 12, 2022

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2021

Accesswire February 10, 2022

Integrated BioPharma Reports Results for its Quarter Ended September 30, 2021

Accesswire November 10, 2021

Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2021

Accesswire September 2, 2021

Integrated BioPharma Reports Results for its Quarter Ended March 31, 2021

Accesswire May 13, 2021

OTC Markets Group Announces Quarterly Index Performance and Rebalancing

PR Newswire April 15, 2021

Integrated BioPharma Announces Launch of Investors Website

Accesswire April 8, 2021

Integrated BioPharma Reports Results for its Quarter Ended December 31, 2020

Accesswire February 12, 2021

Integrated BioPharma Announces Upgrade to OTCQX

Accesswire January 22, 2021

OTC Markets Group Welcomes Integrated BioPharma, Inc. to OTCQX

PR Newswire January 22, 2021